Themis Beteiligungs AG sells shares in Dermapharm
Frankfurt — McDermott Will & Emery advises Joh. Berenberg, Gossler & Co. KG (Berenberg) as Sole Global Coordinator and Sole Bookrunner on the sale of shares in Dermapharm Holding SE by Themis Beteiligungs-Aktiengesellschaft. The transaction volume amounts to approximately EUR 250 million.
Dermapharm is a leading manufacturer of off-patent branded pharmaceuticals for selected markets in Germany.
The McDermott team led by partners Simon Weiß and Joseph W. Marx regularly advises Berenberg on capital market transactions, most recently on the capital increase of CORESTATE Capital Holding S.A. and the capital measure of CompuGroup Medical SE & Co. KGaA.
Advisor Berenberg: McDermott Will & Emery (Frankfurt)
Simon Weiß (Capital Markets) and Joseph W. Marx (US Capital Markets, both Lead), Andrea Adele Stockhorst (Financial Regulatory); Associate: Isabelle Müller (Corporate)
Inhouse Berenberg: Dr. Martin Kniehase (Head of Investment Banking Legal Continental Europe, Director) and Vanessa Harms, LL.M. (Associate Director, Investment Banking Legal)
About McDermott Will & Emery
McDermott Will & Emery Attorneys Tax LLP is a leading international law firm. With over 1,200 attorneys, we are represented in 20 locations worldwide: Atlanta, Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt a.M., Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, San Francisco, Silicon Valley, Washington, D.C. and Wilmington. The German practice is managed by McDermott Will & Emery Rechtsanwälte Steuerberater LLP. www.mwe.com